AU2007906570A0 - Compounds for treating cancer - Google Patents

Compounds for treating cancer

Info

Publication number
AU2007906570A0
AU2007906570A0 AU2007906570A AU2007906570A AU2007906570A0 AU 2007906570 A0 AU2007906570 A0 AU 2007906570A0 AU 2007906570 A AU2007906570 A AU 2007906570A AU 2007906570 A AU2007906570 A AU 2007906570A AU 2007906570 A0 AU2007906570 A0 AU 2007906570A0
Authority
AU
Australia
Prior art keywords
compounds
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007906570A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genscreen Pty Ltd
Royal Alexandra Hospital for Children
Original Assignee
Genscreen Pty Ltd
Royal Alexandra Hospital for Children
Filing date
Publication date
Application filed by Genscreen Pty Ltd, Royal Alexandra Hospital for Children filed Critical Genscreen Pty Ltd
Publication of AU2007906570A0 publication Critical patent/AU2007906570A0/en
Assigned to Genscreen Pty Ltd, THE ROYAL ALEXANDRA HOSPITAL FOR CHILDREN reassignment Genscreen Pty Ltd Alteration of Name(s) of Applicant(s) under S113 Assignors: THE ROYAL ALEXANDRA HOSPITAL FOR CHILDREN
Abandoned legal-status Critical Current

Links

AU2007906570A 2007-11-30 Compounds for treating cancer Abandoned AU2007906570A0 (en)

Publications (1)

Publication Number Publication Date
AU2007906570A0 true AU2007906570A0 (en) 2007-12-13

Family

ID=

Similar Documents

Publication Publication Date Title
HK1200363A1 (en) Compounds useful for treating cancer
HK1131577A1 (en) Compositions for treating cancer
PL2303021T3 (en) Compounds for the treatment of cancer
IL197914A (en) Anti-ereg antibodies for treating cancer
HK1137158A1 (en) Formulations for cancer treatment
AU2007288337A8 (en) Compounds for treating proliferative disorders
ZA201003123B (en) Thiazol derivavtives for treating cancer
IL213398A0 (en) Compounds for treating cancer
AU2008263581A8 (en) Well treatment
EP2144888A4 (en) Methods for treating cancer
EP2029172A4 (en) Anti-c35 antibodies for treating cancer
EP1986656A4 (en) Withacnistin compounds for treatment of cancer
HK1254607A1 (en) Organoarsenic compound for the treatment of cancer
EP2068911A4 (en) Methods for treating cancer
GB0707556D0 (en) Treatment for cancer
AU2007906570A0 (en) Compounds for treating cancer
AU2007901333A0 (en) Method for the treatment of cancer
GB0619271D0 (en) Treating cancer
AU2007900499A0 (en) Therapy for vitiligo
GB0604114D0 (en) Combinations for the treatment of cancer
AU2008902090A0 (en) Cancer Therapy
GB0700493D0 (en) Cancer treatment
GB0723503D0 (en) Cancer treatment
AU2007906387A0 (en) Retrometabolic compounds
AU2007904732A0 (en) Compounds